pVHL status in clear cell renal cell carcinoma regulates HIF-α and E-cadherin expression levels and their implications for tumor progression
Upsala Journal of Medical Sciences · 2025
DOI: 10.48101/ujms.v130.12982 ↗Kurz gefasst
Fachartikel in der Zeitschrift Upsala Journal of Medical Sciences, 2025. Verfasst von Raviprakash T Sitaram und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Odontology, Umeå University, Umeå, Sweden. Hauptthemen laut MEDLINE: Carcinoma, Renal Cell, Cadherins, Hypoxia-Inducible Factor 1, alpha Subunit, Von Hippel-Lindau Tumor Suppressor Protein. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Objectives
This study aimed to determine the effects of von Hippel–Lindau protein (VHL) expression on hypoxia-inducible factor (HIF) and E-cadherin proteins. Furthermore, to evaluate the influence of the VHL–HIF–E-cadherin pathway in clear cell renal cell carcinoma (ccRCC). Materials and Methods: This study used tissue samples collected from 150 patients with ccRCC and 24 adjacent kidney cortex samples. Immunoblotting was performed to measure the expression levels of VHL and E-cadherin. Additionally, nuclear expression of HIF-α was evaluated by immunohistochemistry (IHC) using a tissue microarray (TMA). Results: pVHL levels were lower in ccRCC than in the adjacent kidney cortex; however, pVHL levels showed no correlation with clinicopathological parameters. Nuclear HIF-1α levels were higher in stage IV tumors, whereas HIF-2α levels increased with tumor size. No correlation was observed between HIF-3α levels and clinicopathological parameters. E-cadherin protein expression was reduced in ccRCC tissues and in higher-stage and larger tumors. In pVHL-high ccRCC, E-cadherin levels were lower in advanced-stage and larger tumors. Higher levels of HIF-1α and HIF-3α were observed in pVHL-low tumors. E-cadherin expression negatively correlated with nuclear HIF-1α expression. In pVHL-high ccRCCs, E-cadherin was negatively correlated with HIF-1α, while in pVHL-low ccRCCs, E-cadherin was negatively correlated with HIF-2α. E-cadherin was not associated with cancer-specific survival in patients with pVHL-low tumors, whereas E-cadherin expression was linked to improved survival in patients with pVHL-high tumors.
Conclusion
VHL inactivation causes HIF-α activation and suppresses E-cadherin expression, thereby promoting ccRCC progression. This study provides insights into the potential biomarkers and therapeutic targets for ccRCC treatment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Odontology, Umeå University, Umeå, Sweden.
- Department of Diagnostics and Intervention, Urology and Andrology, Umeå University, Umeå, Sweden.
Zitieren
APA
Sitaram, R. T., & Ljungberg, B. (2025). pVHL status in clear cell renal cell carcinoma regulates HIF-α and E-cadherin expression levels and their implications for tumor progression. Upsala Journal of Medical Sciences. https://doi.org/10.48101/ujms.v130.12982
Vancouver
Sitaram RT, Ljungberg B. pVHL status in clear cell renal cell carcinoma regulates HIF-α and E-cadherin expression levels and their implications for tumor progression. Upsala Journal of Medical Sciences. 2025. doi:10.48101/ujms.v130.12982
BibTeX
@article{Sitaram2025,
author = {Sitaram, Raviprakash T and Ljungberg, Börje},
title = {pVHL status in clear cell renal cell carcinoma regulates HIF-α and E-cadherin expression levels and their implications for tumor progression},
journal = {Upsala Journal of Medical Sciences},
year = {2025},
doi = {10.48101/ujms.v130.12982}
}
EUVIMED